Waters (NYSE:WAT – Get Free Report)‘s stock had its “outperform” rating reissued by research analysts at Sanford C. Bernstein in a research note issued on Friday,Benzinga reports. They currently have a $435.00 price target on the medical instruments supplier’s stock. Sanford C. Bernstein’s price target points to a potential upside of 15.63% from the stock’s […]

Guardant Health (NASDAQ:GH – Get Free Report)‘s stock had its “outperform” rating reissued by research analysts at Sanford C. Bernstein in a research report issued to clients and investors on Friday,Benzinga reports. They presently have a $175.00 price target on the stock. Sanford C. Bernstein’s target price would indicate a potential upside of 22.43% from […]